EAST RUTHERFORD, N.J., March 21 /PRNewswire-FirstCall/ -- Cambrex
Corporation (NYSE: CBM) announced today that one of its customers is
recalling one of their products for which Cambrex currently supplies the
active pharmaceutical ingredient (API). Based on information provided to
date, the recall decision is not linked in any way to Cambrex's performance
as the manufacturer of the API. While this event may materially affect
Cambrex's 2008 performance, until the customer has resolved the issue, it
is unknown what the impact will be. The Company will monitor the situation
and update its 2008 guidance, if necessary, when it has enough information
to do so.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )
About Cambrex
Cambrex provides products and services to accelerate the development
and commercialization of small molecule active pharmaceutical ingredients
("APIs"), advanced intermediates and other products for branded and generic
pharmaceuticals. The Company currently employs approximately 850 people
worldwide. For more information, please visit http://www.cambrex.com.
SOURCE Cambrex Corporation
 back to top
Related links:
http://www.cambrex.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
http://www.prnewswire.com/comp/134219.html /
CONTACT:
Stephanie LaFiura, IR Associate of Cambrex
Corporation, +1-201-804-3037, stephanie.lafiura@cambrex.com
|
